Investigation by Former FBI Director Louis Freeh Finds Congressional Drug Importation Proposals Would Pose Significant Threats

Law Enforcement Would Carry Costs and Burdens Related to Opening U.S. Drug Supply to Increased Threat of Foreign-Sourced Counterfeits

“Permitting prescription drug importation would lead to an increased flow of counterfeit and other potentially dangerous products across U.S. borders, worsen the opioid crisis, and cause unnecessary strain on law enforcement and already-overburdened government regulators, according to the findings of an investigation led by Former Federal Bureau of Investigation (FBI) Director Louis J. Freeh and released in a report today.”